Fig. 3.
Fig. 3. The effects of IL-10 on proliferation and differentiation of B-CLL cells. (A) 3H-thymidine incorporation measured in 4 × 105 MNCs following culture for 7 days with either medium alone, 5 to 100 ng/mL of IL-10, 100 ng/mL TPA, or TPA plus 5 to 100 ng/mL of IL-10. Experiments were performed in triplicate and represent the mean ± SEM for five B-CLL patients. (B) IgM concentration in supernatants from 4 × 106 MNCs cultured under the same culture conditions as (A), but with 25 ng/mL of IL-10. Experiments in (B) were performed in triplicate and represent the mean ± SEM for 10 B-CLL patients. The MNCs studied for proliferation and differentiation contained a median of 96.5% CD19/CD5 positive B-CLL cells.

The effects of IL-10 on proliferation and differentiation of B-CLL cells. (A) 3H-thymidine incorporation measured in 4 × 105 MNCs following culture for 7 days with either medium alone, 5 to 100 ng/mL of IL-10, 100 ng/mL TPA, or TPA plus 5 to 100 ng/mL of IL-10. Experiments were performed in triplicate and represent the mean ± SEM for five B-CLL patients. (B) IgM concentration in supernatants from 4 × 106 MNCs cultured under the same culture conditions as (A), but with 25 ng/mL of IL-10. Experiments in (B) were performed in triplicate and represent the mean ± SEM for 10 B-CLL patients. The MNCs studied for proliferation and differentiation contained a median of 96.5% CD19/CD5 positive B-CLL cells.

Close Modal

or Create an Account

Close Modal
Close Modal